Neuraxis, Inc.
NRXSBiotechnology
$7.55−0.26%As of Oct 29vs prior close
- Market cap
- $94.8M
- P/E (TTM)
- –
- From 52W high
- −14.30%
- EPS (LTM)
- -$0.77
- Revenue (LTM)
- $5.3M
- Net margin
- -144.44%
Nomior Score
62
Emerging BreakoutSpeculativeTop 22% of the scored universe
Growth72
Quality36
Value49
Momentum94
Resilience38
Growth
+9.96%revenue a year over 3 fiscal years
YE22 $2.7MLTM $5.3M
Connections
Revenue to profitQ2 YE26
The operating loss was 110% of revenue, narrower by 82 pts on a year.
Who owns it
1fund